Indian Company Master Data Made Simple
Concord Drugs Limited
Profile data last updated: 23/12/2025
Since 1995, Concord Drugs Limited has maintained a presence in the industry for 30 years. Its CIN is L24230TG1995PLC020093, with registration number 20093. It is officially registered under the category of company limited by shares. Authorized capital of the company is recorded at ₹15.50 crore. Paid-up capital currently stands at ₹13.18 crore.
Its principal business sector is manufacture of chemicals and chemical products. It is registered in Hyderabad. It is incorporated at Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000. It is officially listed as an active business entity. The entity’s PAN (Permanent Account Number) stands as AAACC8171D. The firm is registered with LEI code 98450014CO7460A4A188. For inquiries or official matters, please email [email protected]. At the helm are Koni Reddy Seelam (CFO) and Koni Reddy Seelam (CFO).
Company Overview
- CIN
- Date of Incorporation
- 24/04/1995
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 2024-03-31
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹15,50,00,000.00
- Paid up Capital
- ₹13,17,50,000.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAACC8171D1ZT | Inactive |
| Telangana | 36AAACC8171D1ZV | Active |
| Uttarakhand | 05AAACC8171D1Z0 | Inactive |
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹484.79L | ₹398.40L | ₹491.18L | ₹443.75L | ₹0.00L |
| Investment Properties | ₹63.95L | ₹63.95L | ₹63.95L | ₹63.95L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹3,102.81L | ₹2,498.86L | ₹2,652.66L | ₹2,808.45L | ₹0.00L |
| Tangible Book Value | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹2,836.06L | ₹0.00L |
| Long Term Debt | ₹132.44L | ₹64.54L | ₹191.13L | ₹169.45L | ₹0.00L |
| Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Long Term Provisions | ₹271.88L | ₹252.88L | ₹246.38L | ₹208.38L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,791.94L | ₹1,687.33L | ₹1,505.34L | ₹1,473.97L | ₹0.00L |
| Total Assets | ₹6,514.18L | ₹5,880.64L | ₹5,823.10L | ₹5,644.51L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹2,836.06L | ₹0.00L |
| Gross PPE | ₹1,356.86L | ₹1,266.67L | ₹1,320.42L | ₹3,703.53L | ₹0.00L |
| Common Stock | ₹1,000.00L | ₹1,000.00L | ₹931.55L | ₹874.38L | ₹0.00L |
| Total Capitalization | ₹3,543.81L | ₹3,446.32L | ₹3,361.57L | ₹3,005.51L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹1,924.38L | ₹1,751.87L | ₹1,696.47L | ₹1,643.42L | ₹0.00L |
| Other Equity Interest | ₹2,411.36L | ₹2,381.78L | ₹56.48L | ₹1,961.68L | ₹0.00L |
| Other Non Current Liabilities | -₹0.02L | ₹0.01L | -₹0.01L | -₹0.01L | ₹0.00L |
| Capital Stock | ₹1,000.00L | ₹1,000.00L | ₹931.55L | ₹874.38L | ₹0.00L |
| Additional Paid In Capital | ₹858.94L | ₹858.93L | ₹701.50L | ₹570.00L | ₹0.00L |
| Total Non Current Assets | ₹2,437.97L | ₹2,128.87L | ₹1,477.45L | ₹1,455.45L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹22.54L | ₹17.64L | ₹9.94L | ₹6.54L | ₹0.00L |
| Invested Capital | ₹5,335.75L | ₹5,133.65L | ₹4,866.91L | ₹4,479.48L | ₹0.00L |
| Net Tangible Assets | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹2,836.06L | ₹0.00L |
| Cash And Cash Equivalents | ₹12.09L | ₹14.54L | ₹7.84L | ₹4.44L | ₹0.00L |
| Prepaid Assets | ₹109.21L | ₹153.74L | ₹721.79L | ₹61.42L | ₹0.00L |
| Stockholders Equity | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹2,836.06L | ₹0.00L |
| Other Short Term Investments | ₹10.45L | ₹3.10L | ₹2.10L | ₹2.10L | ₹0.00L |
| Share Issued | ₹100.00L | ₹100.00L | ₹93.15L | ₹87.44L | ₹0.00L |
| Current Assets | ₹4,076.21L | ₹3,751.77L | ₹4,345.64L | ₹4,189.07L | ₹0.00L |
| Working Capital | ₹1,458.19L | ₹1,651.31L | ₹2,184.16L | ₹1,824.37L | ₹0.00L |
| Net Debt | ₹1,912.29L | ₹1,737.33L | ₹1,688.63L | ₹1,638.98L | ₹0.00L |
| Ordinary Shares Number | ₹100.00L | ₹100.00L | ₹93.15L | ₹87.44L | ₹0.00L |
| Current Debt | ₹1,791.94L | ₹1,687.33L | ₹1,505.34L | ₹1,473.97L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹132.44L | ₹64.54L | ₹191.13L | ₹169.45L | ₹0.00L |
| Current Liabilities | ₹2,618.02L | ₹2,100.46L | ₹2,161.48L | ₹2,364.70L | ₹0.00L |
| Net PPE | ₹1,356.86L | ₹1,266.67L | ₹1,320.42L | ₹1,378.31L | ₹0.00L |
| Retained Earnings | ₹1,511.43L | ₹1,481.85L | ₹1,439.91L | ₹1,350.68L | ₹0.00L |
| Construction In Progress | ₹199.65L | ₹163.05L | ₹92.09L | ₹55.39L | ₹0.00L |
| Common Stock Equity | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹2,836.06L | ₹0.00L |
| Inventory | ₹2,526.87L | ₹2,292.31L | ₹2,006.47L | ₹1,748.99L | ₹0.00L |
| Other Properties | ₹1,157.21L | ₹1,103.62L | ₹1,228.33L | ₹1,010.36L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | -₹2.45L | ₹6.71L | ₹2.15L | ₹0.89L | ₹0.00L |
| Financing Cash Flow | -₹142.82L | ₹28.34L | ₹62.40L | ₹167.86L | ₹0.00L |
| Free Cash Flow | ₹138.92L | -₹22.57L | ₹80.65L | -₹168.19L | ₹0.00L |
| Investing Cash Flow | -₹231.82L | -₹100.86L | -₹226.56L | -₹244.39L | ₹0.00L |
| End Cash Position | ₹12.09L | ₹14.54L | ₹7.84L | ₹4.44L | ₹0.00L |
| Capital Expenditure | -₹233.27L | -₹101.79L | -₹85.66L | -₹245.61L | ₹0.00L |
| Beginning Cash Position | ₹14.54L | ₹7.84L | ₹5.69L | ₹3.55L | ₹0.00L |
| Operating Cash Flow | ₹372.19L | ₹79.23L | ₹166.30L | ₹77.42L | ₹0.00L |
| Issuance Of Capital Stock | ₹0.00L | ₹68.45L | ₹188.67L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.43L |
| EBITDA | ₹411.32L | ₹405.18L | ₹460.28L | ₹568.93L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹4,524.46L | ₹4,492.45L | ₹5,208.06L | ₹5,895.65L |
| Total Unusual Items | ₹0.00L | ₹0.00L | -₹1.48L | -₹514.86L |
| Total Expenses | ₹4,246.89L | ₹4,238.70L | ₹4,904.00L | ₹4,979.65L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | -₹149.71L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | -₹1.48L | -₹514.86L |
| Interest Income Non Operating | ₹1.44L | ₹0.92L | ₹0.60L | ₹1.23L |
| Interest Expense Non Operating | ₹199.10L | ₹186.75L | ₹172.83L | ₹167.67L |
| Interest Income | ₹1.44L | ₹0.92L | ₹0.60L | ₹1.23L |
| General And Administrative Expense | ₹12.33L | ₹16.88L | ₹20.57L | ₹22.66L |
| Net Income From Continuing And Discontinued Operation | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.43L |
| Reconciled Depreciation | ₹143.08L | ₹155.54L | ₹162.56L | ₹176.45L |
| Net Income Continuous Operations | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.44L |
| Reconciled Cost Of Revenue | ₹3,523.04L | ₹3,325.41L | ₹4,100.49L | ₹4,213.65L |
| Operating Income | ₹277.57L | ₹253.75L | ₹304.06L | ₹916.00L |
| Net Income | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.43L |
| Diluted Average Shares | ₹100.00L | ₹100.00L | ₹93.15L | ₹87.44L |
| Selling And Marketing Expense | ₹15.07L | ₹15.30L | ₹18.76L | ₹12.10L |
| Total Other Finance Cost | ₹10.80L | ₹5.03L | ₹7.24L | ₹10.13L |
| Normalized Income | ₹33.62L | ₹47.23L | ₹98.55L | ₹524.58L |
| Net Non Operating Interest Income Expense | -₹208.46L | -₹190.86L | -₹179.47L | -₹176.57L |
| EBIT | ₹268.24L | ₹249.64L | ₹297.72L | ₹392.48L |
| Gross Profit | ₹1,001.42L | ₹1,167.04L | ₹1,107.57L | ₹1,682.00L |
| Diluted NIAvailto Com Stockholders | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.43L |
| Cost Of Revenue | ₹3,523.04L | ₹3,325.41L | ₹4,100.49L | ₹4,213.65L |
| Net Interest Income | -₹208.46L | -₹190.86L | -₹179.47L | -₹176.57L |
| Normalized EBITDA | ₹411.32L | ₹405.18L | ₹460.28L | ₹1,083.79L |
| Operating Expense | ₹723.85L | ₹913.29L | ₹803.51L | ₹766.00L |
| Net Income Common Stockholders | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.43L |
| Pretax Income | ₹69.14L | ₹62.89L | ₹124.89L | ₹224.81L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹27.40L | ₹32.18L | ₹39.33L | ₹34.76L |
| Total Revenue | ₹4,524.46L | ₹4,492.45L | ₹5,208.06L | ₹5,895.65L |
| Other Operating Expenses | ₹89.92L | ₹117.94L | ₹109.72L | ₹74.30L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹199.10L | ₹186.75L | ₹172.83L | ₹167.67L |
| Basic Average Shares | ₹100.00L | ₹100.00L | ₹93.15L | ₹87.44L |
| Net Income Including Noncontrolling Interests | ₹33.62L | ₹47.23L | ₹98.55L | ₹159.44L |
| Tax Provision | ₹35.52L | ₹15.66L | ₹26.34L | ₹65.37L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 04/04/2003 | Nagi Reddy Seelam | 01764665 | Managing Director | View other directorships |
| 10/06/2011 | Koni Reddy Seelam | 02829319 | Whole-time director | View other directorships |
| 30/03/2015 | Koni Reddy Seelam | *****3654R | CFO | |
| 30/03/2019 | Ramchandra Reddy Kommula | 02285257 | Director | View other directorships |
| 13/02/2021 | Nagavenkatahareeshkumar Solleti | 09066790 | Director | View other directorships |
| 13/08/2021 | Seelam Manojkumarreddy | 06991382 | Whole-time director | View other directorships |
| 01/06/2022 | Sumeela Kasu | 09571540 | Director | View other directorships |
| 19/03/2024 | Namratha | *****5746C | Company Secretary | |
| 30/09/2025 | Satyam Reddy Gopidi | 11282375 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 06/12/2024 | Form MGT-7-06122024_signed | - |
| 11/11/2024 | Form AOC-4(XBRL)-09112024 | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AA2067506 | 11/03/2022 | ₹5,00,00,000.00 | Icici Bank Limited |
| AB0343271 | 17/12/2011 | ₹18,25,00,000.00 | State Bank Of India |
| B62827605 | 10/11/2005 | ₹1,40,00,000.00 | Punjab National Bank |
| R21816855 | 01/01/1998 | ₹50,00,000.00 | Small Industries Development Bank Of India |
| R21817135 | 17/10/1997 | ₹50,00,000.00 | Small Industries Development Bank Of India |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000
Frequently Asked Questions
What is the incorporation date of Concord Drugs Limited?
The incorporation date of Concord Drugs Limited is 24/04/1995.
What is the authorized share capital and paid-up capital of Concord Drugs Limited?
The authorized share capital of Concord Drugs Limited is ₹15,50,00,000.00. The paid-up capital is ₹13,17,50,000.00.
Who are the current board members & directors of Concord Drugs Limited?
The current board member of Concord Drugs Limited are:
- Nagi Reddy Seelam
- Koni Reddy Seelam
- Koni Reddy Seelam
- Seelam Manojkumarreddy
- Nagavenkatahareeshkumar Solleti
- Sumeela Kasu
- Ramchandra Reddy Kommula
- Satyam Reddy Gopidi
- Namratha
What is the registered address of Concord Drugs Limited?
The registered address of Concord Drugs Limited is Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000.
What is the Corporate Identification Number of Concord Drugs Limited?
The Corporate Identification Number of Concord Drugs Limited is L24230TG1995PLC020093.